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Objectives: Subthalamic nucleus deep-brain stimulation (STN-DBS) is suggested as a standard treatment
for patients with Parkinson's disease (PD) and drug-related side effects. Most centers perform the
operation under local anesthesia (LA) to ensure better microelectrode recording (MER). Given the ad-
vances in imaging and MER, general anesthesia (GA) is perceived as an alternative choice for PD patients
undergoing STN-DBS. However, the outcomes in terms of clinical symptoms and MER after GA have
rarely been reported. In this report, we compared the outcomes after STN-DBS for PD between patients
receiving LA and GA.
Materials and Methods: We included 16 patients with comparable severity of PD undergoing either GA
(n ¼ 8) or LA (n ¼ 8) for STN-DBS. MER was performed in all patients for STN localization, and surgical
outcomes were evaluated using the Uniﬁed PD Rating Scales, and Mini-mental status examination. All
adverse effects were documented.
Results: Both groups (GA and LA) acquired similar beneﬁts from STN-DBS, and there were no signiﬁcant
differences in neuropsychiatric outcome analysis between groups. There were no signiﬁcant differences
in stimulation parameters and adverse effects from STN-DBS between groups. The GA group had a trend
toward a lower frequency rate of STN ﬁring on MER.
Conclusion: Although the GA group has a lower neuronal ﬁring frequency in the STN during surgery,
STN-DBS under GA showed comparable and non-inferior outcomes as compared with STN-DBS under LA.
Copyright © 2016, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).1. Introduction
The efﬁcacy of subthalamic nucleus deep-brain stimulation
(STN-DBS) for Parkinson's disease (PD) has been well documented
in long-term follow-up studies. It offers patients with
medication-related side effects a better quality of life as
compared with using medication alone [1,2]. Given the impera-
tive role of the electrode position within the target nucleus for
DBS, delineation of the “intraventricular” nuclei with imaging andry, Buddhist Tzu Chi General
lien, Taiwan. Tel.: þ886 3
Y. Chen).
lief Tzu Chi Foundation. Publisheddetailed electrophysiological mapping with microelectrode
recording (MER) are the most powerful tools available to improve
surgical outcomes [3]. Adverse effects from STN-DBS are rare and
most can be improved with adjustment of the DBS parameters.
DBS for neuropsychiatric diseases is usually performed in awake
patients under local anesthesia (LA) to provide the most accurate
neural characteristics of the target nucleus. However, intra-
operative safety risks and postoperative psychosis, although rare,
increase in awake patients undergoing long cranial surgeries [4]. It
is still debated whether neuromodulation surgery with intra-
operative electrophysiological localization could be performed
under general anesthesia (GA). There is a paucity of reports directly
comparing PD symptoms after STN-DBS between patients who had
GA or LA.by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
Table 1
Pre-operative status between GA and LA.
Clinical demographics GA (n ¼ 8) LA (n ¼ 8)
Age of onset, y 49.6 ± 7.1 41.1 ± 10.2
Disease duration, y 9.3 ± 2.4 12.4 ± 9.2
Pre-op Levodopa response (%)
Part I 39.9 ± 27.7 30.0 ± 13.9
Part II 54.3 ± 30.1 49.0 ± 27.1
Part III 41.7 ± 29.4 39.9 ± 16.3
Brady 41.5 ± 21.0 32.3 ± 17.3
Tremor 33.8 ± 67.4 39.3 ± 44.4
Rigidity 49.2 ± 43.3 54.3 ± 23.4
Posture & Gait 41.9 ± 29.4 43.1 ± 27
Axial 35.7 ± 25.6 34.4 ± 22.3
Total 41.1 ± 25.9 35.2 ± 13.2
Part IV score 6.1 ± 3.1 4.6 ± 3.5
H&Y stagea 3.0 ± 0.5 2.9 ± 0.6
SEADL scorea (%) 68.8 ± 18.9 66.3 ± 17.7
Data are presented as mean ± standard deviation.
GA ¼ general anesthesia; H&Y ¼ Hohen and Yahr; LA ¼ local anesthesia; SEADL ¼
Schwab and England activity of daily living score; STN-DBS ¼ subthalamic nucleus
deep-brain stimulation; UPDRS ¼ uniﬁed Parkinson's Disease rating scale.
a H&Y stage and SEADL were expressed in Med off status.
Table 2
STN-DBS effectiveness (%) between preoperative and postoperative status in both
groups.
GA pa LA pa
Part I 36.2 ± 31.7 0.0127 * 35.7 ± 15.9 0.0053 **
Part II 41.8 ± 51.0 0.0102 * 49.2 ± 26.6 0.0028 **
Part III 41.5 ± 35.8 0.0008 ** 45.8 ± 26.2 0.0003 **
Brady 31.0 ± 10.1 0.0013 ** 33.5 ± 25.8 0.0016 **
Tremor 69.8 ± 38.5 0.0082 ** 76.2 ± 38.1 0.0085 **
Rigidity 59.0 ± 1.9 0.0028 ** 61.3 ± 38.2 0.0056 **
Posture & Gait 29.7 ± 32.8 0.0080 ** 33.3 ± 33.2 0.0199 *
Axial 34.0 ± 35.0 0.0109 * 31.9 ± 40.3 0.0094 **
Part IV 43.3 ± 0.6 0.0050 ** 39.5 ± 4.9 0.0100 *
Total 38.5 ± 41.7 0.0013 ** 46.0 ± 30.9 0.0006 **
Hoehn & Yahr Stage 28.1 ± 23.7 0.0050 ** 32.2 ± 20.2 0.0479 *
SEADL Score 73.8 ± 11.9 0.0038 ** 86.3 ± 10.6 0.0035 **
Data are presented as mean ± standard deviation.
* p < 0.05.
** p < 0.01.
GA ¼ general anesthesia; H&Y ¼ Hohen and Yahr; LA ¼ local anesthesia; SEADL ¼
Schwab and England activity of daily living score; STN-DBS ¼ subthalamic nucleus
deep-brain stimulation.
a The pevalue represents a comparison to preoperative status.
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propofol led to signiﬁcant damping of MER during STN-DBS for PD
[5]. In our previous study, we showed that inhalation anesthetics
could ensure adequate recording of neural ﬁring during STN-DBS.
We therefore analyzed clinical and electrophysiological outcomes
between PD patients who had GA or LA [6].
2. Materials and methods
2.1. Patient selection
From January 2010 to December 2014, 16 PD patients who
underwent bilateral STN-DBS at Tzu Chi General Hospital, Hua-
lien, Taiwan were enrolled in this comparison study. Eight were
assigned to the GA group and received desﬂurane GA with
endotracheal intubation during bilateral STN-electrode implan-
tation, and eight patients were assigned to the LA group and
received regional anesthesia in the scalp. The type of anesthesia
was determined by patient preference after comprehensive
explanation of the pros and cons of different anesthetic strategies.
Considerations in choosing the anesthetic method generally
included ability of the patient to stay alert and cooperate during
the entire DBS procedure and risks of GA in terms of medical
status. The inclusion criteria for PD patients included: (1) signif-
icant positive response on a levodopa test [United PD Rating Scale
(UPDRS) part III > 30% improvement in score]; (2) preoperative
brain magnetic resonance imaging (MRI) ruling out structural
abnormalities (i.e., stroke, traumatic brain injury, encephalopathy,
etc.) and showing cerebral vasculature; and (3) no active psy-
chiatric or severe medical diseases. This study was approved by
the Institutional Review Board of Tzu Chi General Hospital (No.
103-09-B).
2.2. Preoperative imaging planning
Before the date of operation, cranial images were obtained with
a 1.5-tesla magnetic resonance (MR) unit (General Electric, Rahway,
NJ, USA). The standard settings comprised T1-weighted axial im-
ages at 0.75-mm thickness, T2-weighted axial images at 2-mm
thickness, and T1-weighted images with contrast (delineation of
vasculature in cases of inadvertent injury). Each of these sequences
was performed in contiguous axial slices. The images were trans-
ferred to the Stealth neuronavigation workstation (Medtronic,
Minneapolis, MN, USA). The image fusion software fused all three
sets of MR images. The tentative surgical target coordinates for the
tip of the permanent implantable electrode were set at the central
lowest border of the STN by direct visualization from brain MRI
(direct targeting) and adjusted according to the relative position of
the anterior commissureeposterior commissure (AC-PC) line and
red nucleus (indirect targeting).
2.3. Stereotactic and anesthetic procedure
On the morning of the operation, a Leksell G-frame (Elekta In-
strument Inc., Norcross, GA, USA) was applied under LA with the
patient sitting in a chair. Both groups of patients (GA and LA) were
then given computed tomography (CT) examinations. The CT im-
ages were fused on preoperative MRI to determine target co-
ordinates. Patients in the LA group were placed in the supine
position with the head of the bed elevated at 30. GA was induced
in the other group of patients by administration of regular narcotic
agents and a muscle relaxant. After intubation, patients were
maintained by desﬂurane inhalation during the entire surgical
course. The depth of anesthesia was maintained at 0.5e1.0 minimal
alveolar concentration, so the patient would not experience acough reﬂex or any change in heart rate or blood pressure during
the MER procedure [6].2.4. MER procedure
Neural ﬁrings obtained from the tip of the microelectrode (FHC,
Bowdoin, ME, USA) were sent to the intraoperative MER system
(Leadpoint; Medtronic) where they were magniﬁed and displayed.
The sampling rate was 24 kHz. For both groups of patients, passive
movement of the contralateral limb was tested during MER in the
STN to observe whether there were any movement-related
neuronal ﬁring changes. The selection of the ﬁnal trajectory for
electrode implantation depended on adequate length of STN hy-
peractivity neuronal ﬁring and the presence of movement-related
ﬁring-pattern changes. In the LA group, stimulation of up to
~4e5 V was done to test for adverse effects and the immediate
effectiveness of each individual electrode. We did not perform any
intraoperative test stimulation in the GA group.
Table 3
Stimulation parameters between GA and LA.
LA
Amp
Ch1
Amp
Ch2
PW
Ch1
PW
Ch2
Rate
Ch1
Rate
Ch2
Ch1 Ch2
1 3.3 3.3 60 60 130 130 1-Cþ 1-Cþ
2 3.7 3.8 60 60 130 130 1-Cþ 1-Cþ
3 2.1 3.6 60 60 130 130 1-Cþ 2-Cþ
4 3.3 3.8 60 60 145 145 1-Cþ 1-Cþ
5 3.4 4.2 60 60 130 130 1-Cþ 1-Cþ
6 2.9 4 60 60 130 130 1-Cþ 1-Cþ
7 2.1 3.8 60 60 130 130 1-Cþ 2-Cþ
8 3.9 3.5 60 60 130 130 1-Cþ 1-Cþ
Mean 3.1 3.8 60.0 60.0 131.9 131.9
SD 0.7 0.3 0.0 0.0 5.3 5.3
GA
1 3.1 3.3 60 60 100 100 1-Cþ 0-Cþ
2 3.3 1.8 60 60 130 130 2-Cþ 1-Cþ
3 3.5 3.7 60 60 100 100 1-Cþ 2-Cþ
4 3.5 3.2 60 60 130 100 1-Cþ 1-Cþ
5 3.4 3.7 60 60 130 130 1-Cþ 1-Cþ
6 3.5 3 60 60 130 130 0-Cþ 1-Cþ
7 3.5 3.9 60 60 130 130 1-Cþ 2-Cþ
8 2.8 2.8 60 60 130 130 1-Cþ 1-Cþ
Mean 3.3 3.2 60.0 60.0 122.5 118.8
SD 0.3 0.7 0 0 13.9 15.5
Amp ¼ amplitude (voltage); Ch1 ¼ channel 1 (left electrode); Ch2 ¼ channel 2 (right electrode); GA ¼ general anesthesia; LA ¼ local anesthesia; PW ¼ pulse wide (mi-
croseconds); Rate ¼ hertz; SD ¼ standard deviation.
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Brain CT imaging was obtained immediately after the operation
in both groups to exclude intracranial hemorrhage and to verify the
initial postoperative electrode coordinates. A pulse generator was
usually implanted 1 week after electrode implantation. A post-
operative active-stimulation test was performed to identify the
maximal effectiveness of contact and related adverse effects.2.6. Clinical outcome analysis
We conducted visits with all patients at the last follow-up after
implanting the DBS electrodes. Each patient was evaluatedwith the
UPDRS under four different conditions. The medication off condi-
tion (Med-off) was deﬁned as when a patient had not taken anti-
parkinsonian medication for at least 12 hours. The DBS off
condition (DBS-off) was deﬁned as when a patient had not received
DBS for 4 hours or for the time of tolerance of the patient
(sometimes < 4 hours due to intolerable symptoms).
To evaluate the effectiveness of STN-DBS or medications, we
compared postoperative UPDRS scores between patients with DBS
on/Med off and those with DBS off/Med off. The extent to which a
patient beneﬁtted from the operation was deﬁned as the percent-
age of change in the difference between UPDRS scores. Neuropsy-
chiatric function was evaluated using the Mini-Mental Status
Examination (MMSE), Cognitive Abilities Screening Instrument
(CASI), and Beck Depression Inventory (BDI).Table 4
MER characteristics between GA and LA.
GA LA p
Firing frequency 34.40 ± 26.16 40.5 ± 20.33 0.09
CV of ISI 1.22 ± 0.33 1.12 ± 0.23 0.56
AI of ISI 0.25 ± 0.15 0.30 ± 0.12 0.21
AI ¼ asymmetric index; CV ¼ coefﬁcient of variance; GA ¼ general anesthesia;
ISI ¼ interspike interval; LA ¼ local anesthesia; MER ¼ microelectrode recording.2.7. MER outcome analysis
The raw data from MER from the 16 PD patients were exported
from the LeadPoint software (Medtronic). Only those recording
tracts utilized as the ﬁnal electrode-implantation site were har-
vested for off-line analysis. We used Spike2 software (version 5.0;
Cambridge Electronic Design, Cambridge, UK) to perform spike
sorting, and ﬁring frequencies of individual STN neurons, as well as
correlation variance and interspike intervals, were calculated from
Neuroexplorer (version 4; Nex Technologies, Boston, MA, USA).
2.8. Statistical analysis
Paired Student t test was used for comparing characteristics
between the two groups and preoperative and versus postoperative
outcomes. Signiﬁcance was set at p < 0.05 for all tests.
3. Results
Although there were no differences in demographic character-
istics, preoperative patients in the LA group seemed to be younger
than those in the GA group (Table 1). The two groups had compa-
rable preoperative disease severity (disease duration, scores for
UPDRS parts IeIV, and Hoehn and Yahr staging).
At the last follow-up after the operation, both groups showed
signiﬁcant improvement from bilateral STN-DBS in UPDRS total
scores and scores for parts IeIV (Table 2). There were also signiﬁ-
cant reductions in the Levodopa equivalent daily dose (LEDD) and a
reduction in motor complications (UPDRS part IV) in both groups.
Analysis did not reveal a signiﬁcant difference in the effectiveness
of STN-DBS between groups. Postoperative neuropsychological
evaluation (GA vs. LA) showed similar results for the MMSE
(25.8 ± 4.0 vs. 27.7 ± 1.4), CASI-II (84.7 ± 14.6 vs. 91.3 ± 10.0), and
BDI (12.0 ± 8.2 vs. 16.7 ± 14.6).
Stimulation parameters of STN-DBS showed nearly the same
results in both groups for amplitude, pulse width, and rate
(p > 0.05; Table 3). The mean coordinates for the postoperative-
stimulation electrodes were similar in the two groups, as well.
Fig. 1. Representative raw neuronal ﬁrings from the subthalamic nucleus in patients with Parkinson's disease under general and local anesthesia.
S.-T. Tsai et al. / Tzu Chi Medical Journal 28 (2016) 63e6766Coordinates according to the AC-PC line in the GA group were
X¼ 10.96 ± 0.69, Y¼2.46 ± 0.52, and Z¼5.96 ± 0, and in the LA
group were X ¼ 10.69 ± 0.39, Y ¼ 2.33 ± 0.42, and
Z ¼ 5.06 ± 0.63.
Firing frequencies in the STN tended to be higher in the LA group
as compared with those in the GA group (p < 0.1); however, both
the coefﬁcients of variance and interspike intervals were not much
different between groups (Table 4, Fig. 1). Postoperative adverse
effects were similar.
4. Discussion
Our results ﬁrst showed that PD patients can have signiﬁcant
improvement in motor disability under conditioned-inhalation GA,
and that this beneﬁt was similar compared with patients under LA
STN-DBS. Although the GA group seemed to have lower ﬁring fre-
quencies in STN neurons during MER, other signatures of neural
ﬁring did not obviate justiﬁcation of the STN position to ensure the
optimal position of electrodes. Based on our knowledge, our reports
are the ﬁrst to provide direct comparison of clinical and electro-
physiological outcomes between GA and LA methods for STN-DBS
in a PD patient cohort in a single center.
While STN-DBS performed under LA has been the mainstream
for PD to ensure accurate MER recording and intraoperative-test
stimulation, several reports demonstrated the sustained long-
term effectiveness of STN-DBS under GA [7e10]. UPDRS part III
scores could be improved signiﬁcantly by STN-DBS under LA, andthe extent of improvement has ranged from 45% to 50% [9,11].
However, Fluchere et al [12] demonstrated signiﬁcant sustained
beneﬁts after 5 years of STN-DBS (improvement of UPDRS III score
in Med off/DBS on was 61% at 1 year and 37% at 5 years) in a large
cohort of PD patients under controlled GA STN-DBS. If we included
those outcomes of GA STN-DBS at other centers, the UPDRS part III
outcome improved from 32% to 63% [13]. These achievements are
similar to those observed from STN-DBS performed under LA. Our
single-institution report not only showed direct comparison of
consecutive PD patients under standard surgical procedures
(except anesthetic modality), but also conﬁrmed non-inferiority of
the efﬁcacy of the GA method (improvement of UPDRS III score in
Med off/DBS on at 5 years was 43.2% in GA vs. 46.8% in LA).
Between-groups analysis also revealed a similar percentage
improvement in LEDD reduction. Both groups had similar stimu-
lation parameters postoperatively.
In addition to the general risks of cranial surgery, most adverse
effects after STN-DBS are attributed to misplacement of DBS or
current diffusion from stimulating contact [14]. Misplacement or
deviation of DBS electrodes is difﬁcult to identify under GA. To
achieve a maximal clinical outcome, the STN-DBS operation in-
volves implantation of electrodes with electrophysiological
reﬁnement and an intraoperative macrostimulation test with im-
mediate patient feedback [15]. Both have been claimed as caveats
for DBS under sedatives. Our results of stimulation parameters,
active-contact coordinates, and similar adverse effects all indicated
similar surgical outcomes for the LA and GA groups. Misplaced
S.-T. Tsai et al. / Tzu Chi Medical Journal 28 (2016) 63e67 67trajectory of MER may lead to more recording time and associated
risks. Additionally, suboptimal placement of DBS electrodes usually
leads to adverse effects from stimulation due to current diffusion or
higher power consumption [16]. Given the advances in imaging
modalities and neurophysiological recording, controlled anesthesia
may provide patients a safe, comfortable operation without
compromising surgical beneﬁts [17e19].
In our previous report, we found that MER can be accurately
recorded in PD patients under inhalation GAwith clinical outcomes
similar to those in STN-DBS performed under LA [6]. Although
propofol can be safely used for STN-DBS, it was shown to dramat-
ically decrease neural activity in the STN [5,17]. The effectiveness of
postoperative outcomes in patients given a combination of keta-
mine and remifentanil for GA STN-DBS were similar to those under
LA, and there were also no signiﬁcant differences in neurophysio-
logical parameters [20]. However, ketamine has been associated
with increased intracranial pressure, which is dose-responsive.
Therefore, ketamine must be carefully titrated in intracranial op-
erations, and it is usually combined with other inhalation anes-
thetics [21]. We only administered inhalation anesthetics
(desﬂurane) as maintenance anesthesia during STN-DBS. Although
the ﬁring frequency of STN neurons was lower in the GA group,
other neurophysiological outcomes did not show much difference
from the LA group. This further highlighted the reliability of using
inhalation anesthetics for DBS without compromising electro-
physiological recording [18].
Advances in brain-imaging techniques (especially intraoperative
ones) have been claimed to preclude use of MER and its rare associ-
ated risks [22]. Deciphering the neural underpinning of PD neuro-
physiology could provide a clearer picture for optimized stimulation
adjustment. Several centers have tried performingoff-line analysis of
neural recording to predict or start individualized stimulation-
parameter combinations before adjusting them based on clinician
experience and patient-trial responses [23]. However, STN-DBS un-
der GA enables neuroscientists or clinicians to record the detailed
neurophysiology of the STN while the patient is unconscious. This
provides an opportunity to better understand how inhalation anes-
thetics inﬂuence single-neuron recording analysis [24].
Limitations of this study include its non-randomized nature. We
tried to include patients with similar disease severity in the two
groups. Additionally, patients all underwent stringent, blinded
preoperative evaluation by other movement specialists, which
should eliminate some selection bias. Also, the number of patients
in both groups was small.
We believe that the STN-DBS operation using LA allows suc-
cessful MER and a convincing intraoperative-macrostimulation
test. Our study provided direct evidence of the similar effective-
ness of STN DBS using GA (with inhalation anesthetics) as
compared with LA for PD patients in a single-hospital experience.
We can providemore options in surgical methods for PD patients to
facilitate widespread beneﬁts from neuromodulation operations.
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